Biogen Inc. (BIIB) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning. My name is Cynthia and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen Second Quarter 2025 earnings call and business update. All lines have been placed on mute to prevent any background noise. After the speakers remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star one on your telephone keypad. Please limit yourself to one question to allow other participants time for questions. If you require any further follow up, you may press star one again to rejoin the queue. Today's conference is being recorded. Thank you. I would now like to turn the conference over to Mr. Tim Power, Head of Investor Relations. Mr. Power, you may begin your conference. Thanks, Cynthia. Good morning, everyone. Welcome to Biogen's Second Quarter 2025 earnings call. During this call, we'll make forward looking statements, which involves risks and uncertainties that may cause actual results to differ materially from our forward looking statements. We provide a comprehensive list of risk factors in our SEC filings, which I encourage you to review. Our earnings release and other documents related to our results, as well as reconciliations between gap and non-gap results discussed on this call can be found on the investor section of Biogen.com. We've also posted the slides to our website that we'll use during the call. On today's call, I'm joined by our president and Chief Executive Officer Chris V. Backer, Dr. Priya Singhal, Head of Development, Alicia Alimo, our President and Head of North America, and Robin Craver, our Chief Financial Officer. We'll make some opening comments and then move to Q&A and to allow us to get through as many questions as possible,...